Article
03 Oct 2024
A Look Ahead In Life Sciences: What We Are Tracking In The Fourth Quarter Of 2024 And Beyond
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
09 Jan 2024
A Look Ahead In Life Sciences: What We Are Tracking In Q1 2024 And Beyond
Article
29 Nov 2023
A Practical Look At OIG's New Compliance Guidance
Article
22 Nov 2023
Significant 340B Drug Pricing Program Litigation May Impact 340B Scope
Article
10 Nov 2023
2023 State Drug Transparency Law Development Update
Article
03 Nov 2023
White House Unveils Landmark Executive Order On Safe, Secure, And Trustworthy Artificial Intelligence
Article
10 Oct 2023
Federal Court Strikes Down Copay Accumulator Programs
Article
11 Apr 2023
CMS Issues Guidance And Solicits Comment On The 2026 Inflation Reduction Act Part D Negotiation Process
Article
22 Mar 2023
HHS To Create New Potential Medicare Pricing Models For Cell And Gene Therapy, Drugs Subject To Accelerated FDA Approval, And "High-Value" Generics
Article
28 Feb 2023
CMS Issues Proposed Guidance On Inflation Rebates Under Medicare Part B
